Prudential Financial Inc. trimmed its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 91.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,632 shares of the health services provider's stock after selling 273,976 shares during the period. Prudential Financial Inc.'s holdings in Teladoc Health were worth $242,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after buying an additional 1,029,829 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $297,000. American Century Companies Inc. raised its position in Teladoc Health by 18.1% in the 4th quarter. American Century Companies Inc. now owns 209,718 shares of the health services provider's stock worth $1,906,000 after purchasing an additional 32,213 shares during the last quarter. Generali Investments Management Co LLC bought a new stake in shares of Teladoc Health during the fourth quarter worth $64,000. Finally, Vinva Investment Management Ltd acquired a new position in shares of Teladoc Health during the fourth quarter valued at $363,000. Institutional investors own 76.82% of the company's stock.
Insider Transactions at Teladoc Health
In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.95% of the stock is owned by company insiders.
Teladoc Health Price Performance
Shares of NYSE:TDOC remained flat at $7.25 during midday trading on Monday. The company had a trading volume of 3,327,989 shares, compared to its average volume of 6,242,104. The company's fifty day moving average is $9.73 and its 200 day moving average is $9.70. Teladoc Health, Inc. has a twelve month low of $6.61 and a twelve month high of $15.21. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market capitalization of $1.27 billion, a PE ratio of -1.26 and a beta of 1.73.
Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of research firms have issued reports on TDOC. The Goldman Sachs Group cut their target price on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Bank of America cut their target price on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research note on Friday. Finally, Piper Sandler cut their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $10.94.
Read Our Latest Research Report on TDOC
Teladoc Health Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
